Loading…
HCW Biologics Inc. is projected to rise to $5.46 by 2027, a +20% move from its current price of $4.55. HCWB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.23 | $4.56 | $4.92 | +0.18% |
| Jul 14 | $4.10 | $4.57 | $5.08 | +0.36% |
| Jul 15 | $4.01 | $4.57 | $5.22 | +0.55% |
| Jul 16 | $3.94 | $4.58 | $5.33 | +0.73% |
| Jul 17 | $3.88 | $4.59 | $5.44 | +0.91% |
| Jul 18 | $3.82 | $4.60 | $5.54 | +1.10% |
| Jul 19 | $3.77 | $4.61 | $5.63 | +1.28% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.77 | $4.61 | $5.63 | +1.28% |
| Week 2 | $3.52 | $4.67 | $6.20 | +2.58% |
| Week 3 | $3.34 | $4.73 | $6.69 | +3.90% |
| Week 4 | $3.21 | $4.79 | $7.15 | +5.23% |
| Week 5 | $3.10 | $4.85 | $7.59 | +6.58% |
| Week 6 | $3.01 | $4.91 | $8.02 | +7.94% |
| Week 7 | $2.93 | $4.97 | $8.45 | +9.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
HCW Biologics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies for chronic, low-grade inflammation and diseases in the United States. It was incorporated in 2018 and is headquartered in Miramar, Florida.
The company operates in the Healthcare sector and its lead products include HCW11-018b, a novel tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that combines cytokines and pembrolizumab; and HCW9302, an injectable interleukin-2 fusion protein complex in clinical trials for alopecia areata. It also develops HCW9201, a reagent for NK cell therapies; HCW9206, a reagent for CAR-therapies; and HCW11-006, a multi-functional immune cell stimulator. HCW Biologics has a license agreement with Wugen Inc.
to develop cell therapy-based treatments and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecule.
HCW Biologics Inc. trades under the symbol HCWB. The current price is $4.62 and the market capitalization is $7.38M, with a rank of 5138. The stock’s near-term picture shows a mixed setup, while the longer-run outlook transitions from neutral to bullish in subsequent years according to the forecasted price path.
The 30-day technical backdrop shows a wide trading window and notable volatility alongside a defined support and resistance framework.
A major floor 94.1% below — a decisive break under it would weaken the trend.
The nearest floor, 5.5% below — buyers have tended to step in here.
The nearest ceiling, 175.6% above — a clean break opens room to run.
A major ceiling 175.6% above — clearing it would confirm fresh momentum.
Key HCWB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HCWB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.54 | Buy | $4.47 | Buy |
| MA 10 | $4.28 | Buy | $4.02 | Buy |
| MA 20 | $2.72 | Buy | $3.24 | Buy |
| MA 50 | $1.83 | Buy | $2.20 | Buy |
| MA 100 | $1.17 | Buy | $1.79 | Buy |
| MA 200 | $1.78 | Buy | $2.83 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 70.51 | Sell |
| Stoch RSI (14) | 65.55 | Neutral |
| CCI (20) | 70.49 | Neutral |
| Williams %R (14) | -15.62 | Info |
| MACD (12,26,9) | 0.20 | Buy |
| ROC (12) | 321.30 | Buy |
| Bollinger %B (20,2) | 0.76 | Neutral |
| Stochastic %K (14) | 84.38 | Sell |
| TRIX (15) | 5.61 | Buy |
| Awesome (5,34) | 2.16 | Buy |
| Ultimate (7,14,28) | 52.12 | Neutral |
| Momentum (10) | 3.43 | Buy |
| Aroon Osc (25) | 4.00 | Buy |
| Hull MA (9) | 4.56 | Sell |
| ADX (14) | 31.47 | Buy |
| ATR (14) | 0.31 | Info |
The 30-day picture carries a BEARISH sentiment. The RSI14 sits at 40, indicating modest downside momentum. The 50-day simple moving average is $6.66 and the 200-day simple moving average is $10.07, placing the price below both averages for now. Support is listed at $4.30 and resistance at $17.34, shaping a clear trading band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.61 | $4.55 | $7.81 | 0% | Neutral | |
| $3.96 | $5.46 | $8.14 | +20% | Bullish | |
| $3.58 | $5.24 | $8.32 | +15% | Neutral | |
| $3.28 | $5.05 | $8.42 | +11% | Neutral | |
| $2.80 | $4.53 | $7.86 | -1% | Neutral | |
| $2.70 | $4.56 | $8.19 | 0% | Neutral | |
| $3.26 | $5.76 | $10.66 | +27% | Bullish | |
| $3.98 | $7.31 | $13.91 | +61% | Bullish | |
| $3.65 | $6.97 | $13.61 | +53% | Bullish | |
| $2.99 | $5.94 | $11.86 | +30% | Bullish | |
| $3.81 | $8.46 | $18.58 | +86% | Bullish | |
| $5.69 | $12.64 | $29.08 | +178% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.61 | $4.55 | $5.49 | +0.00% |
| August 2026 | $3.98 | $4.82 | $6.09 | +6.03% |
| September 2026 | $4.37 | $5.37 | $6.92 | +11.34% |
| October 2026 | $4.39 | $5.46 | $7.16 | +1.71% |
| November 2026 | $4.34 | $5.45 | $7.24 | -0.27% |
| December 2026 | $4.57 | $5.80 | $7.81 | +6.47% |
Click any year to see its month-by-month HCWB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, HCWB is projected to trade between $1.61 and $7.81, averaging $4.55 — a potential gain of 0% from today's $4.55. A consolidation phase looks the most probable path here.
HCW Biologics Inc.'s 2027 outlook centres on $5.46, within a $3.96 to $8.14 range. That is up +20% on the projected 2026 average. That marks a +20% change versus current levels. Momentum favours further upside here.
By 2028, HCWB could reach as high as $8.32, with a base case around $5.24 and support toward $3.58 — roughly +15% from $4.55. A consolidation phase looks the most probable path here.
Expect HCWB to range from $3.28 to $8.42 through 2029. The $5.05 average target implies a +11% move from current prices. That is -4% versus the projected 2028 average. Price action looks broadly range-bound.
The HCWB price prediction for 2030 points to an average of $4.53 (low $2.80, high $7.86) — a potential decline of -1% on today's $4.55. A consolidation phase looks the most probable path here.
In 2031, HCWB is projected to trade between $2.70 and $8.19, averaging $4.56 — a potential gain of 0% from today's $4.55. That is up +1% on the projected 2030 average. Price action looks broadly range-bound.
HCW Biologics Inc.'s 2032 outlook centres on $5.76, within a $3.26 to $10.66 range. That is up +26% on the projected 2031 average. That marks a +27% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, HCWB could reach as high as $13.91, with a base case around $7.31 and support toward $3.98 — roughly +61% from $4.55. Momentum favours further upside here.
Expect HCWB to range from $3.65 to $13.61 through 2034. The $6.97 average target implies a +53% move from current prices. That is -5% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
The HCWB price prediction for 2035 points to an average of $5.94 (low $2.99, high $11.86) — a potential gain of +30% on today's $4.55. Momentum favours further upside here.
In 2040, HCWB is projected to trade between $3.81 and $18.58, averaging $8.46 — a potential gain of +86% from today's $4.55. That is up +43% on the projected 2035 average. Buyers look set to stay in control over this stretch.
HCW Biologics Inc.'s 2050 outlook centres on $12.64, within a $5.69 to $29.08 range. That is up +49% on the projected 2040 average. That marks a +178% change versus current levels. Momentum favours further upside here.
Investing $1,000 in HCWB today (≈ 219.78022 HCWB) could be worth
$2,779.03
+$1,779.03 (+178%) by 2050 · US Dollar
Based on the average projected HCWB price of $12.64 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HCWBwould be worth at today's price.
$1,000 invested in HCWB on Jul 10, 2025 (≈ 226.24434 HCWB) would be worth
$1,029.41
+$29.41 (+2.9%) today · 1.03× · US Dollar
Based on a HCWB entry price of $4.42 vs. today's $4.55.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.3 | $1,058.14 | +5.8% |
| 1 month ago | $1.21 | $3,760.33 | +276.0% |
| 3 months ago | $0.365 | $12,465.75 | +1146.6% |
| 6 months ago | $1.22 | $3,729.51 | +273.0% |
| 1 year ago | $4.42 | $1,029.41 | +2.9% |
| All time (5.0y) ago | $252 | $18.06 | -98.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HCWB forecast.
Our base-case forecast reaches $9.10 around 2050.
Implied market cap at $9.10: $14.53M
Looking out across the multi-year forecast, the asset starts near neutrality in the mid-2020s before entering a bullish phase in the early 2030s. The 2026 average price is $4.62 with a neutral stance and an ROI of 0%. In 2030 the average is forecast at $4.51 with a negative ROI of -2.3% and a neutral sentiment, signaling limited upside that year.
From 2032 onward the outlook turns bullish, with 2032 average $5.95 and ROI 28.9%, 2033 average $7.36 and ROI 59.3%, 2034 average $7.07 and ROI 53%, and 2035 average $6.07 with ROI 31.4%. The bullish trajectory extends to 2040 (average $8.65, ROI 87.2%) and 2050 (average $12.97, ROI 180.7%), with the forecasted sentiment labeled BULLISH from 2032 forward. These are projections and not guarantees, and individual results may vary depending on market conditions and company developments.
Tap a question to reveal the answer.
The min is $2.79, the avg is $4.51, and the max is $7.84, with an ROI of -2.3% and a NEUTRAL sentiment.
The forecast shows NEUTRAL sentiment through 2021-2031 with modest returns around the mid-4s to mid-5s, then a BULLISH shift from 2032 onward, with higher potential ROIs such as 28.9% in 2032, 59.3% in 2033, 87.2% in 2040, and 180.7% in 2050.
Yes. The max forecasts include $14.02 in 2033, $13.81 in 2034, $18.99 as a max in 2040, and $29.83 as a max in 2050.
Current price is $4.62 and the market capitalization is $7.38M.
The 30-day range is $2.65 to $8.06.
HCW Biologics Inc. Community Discussion
0Share your HCW Biologics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.